申请人:Millennium Pharmaceuticals, Inc.
公开号:US20170073326A1
公开(公告)日:2017-03-16
The present invention provides a compound of formula I:
and pharmaceutically acceptable salts thereof, wherein X, R
1
, R
2
, R
3
, R
4
, R
5
, L
1
, L
2
, m, and n, are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.